<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00429468</url>
  </required_header>
  <id_info>
    <org_study_id>M06-835</org_study_id>
    <nct_id>NCT00429468</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Interaction Between Vicodin速 CR and Ethanol in Healthy Male and Female Moderate Alcohol Drinkers</brief_title>
  <official_title>A Single-Centre, Double-Blind, Randomized, Placebo-Controlled, Phase 1 Study to Evaluate the Interaction Between Vicodin速 CR and Ethanol in Healthy Male and Female Moderate Alcohol Drinkers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott</source>
  <brief_summary>
    <textblock>
      The purpose of this research study is to determine if varying strengths of ethanol affect the
      drug level and safety profile of Vicodin速 CR.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Standard pharmacokinetic assessments</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>statistical, clinical and laboratory procedures</measure>
  </primary_outcome>
  <enrollment>25</enrollment>
  <condition>Drug Interactions</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vicodin速 CR (extended-release hydrocodone/acetaminophen)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females ages 19 to 55

          -  If female, must be of non-child bearing potential or practicing birth control

          -  Current alcohol users who are classified as moderate drinkers (defined as 7-21 drinks
             per week)

        Exclusion Criteria:

          -  Intolerance towards ethanol

          -  Is allergic to or has a serious reaction to hydrocodone, other opioids, or
             acetaminophen

          -  Significant GI narrowing or abnormality with a potential to inhibit GI motility or
             tablet transport

          -  History of seizures or convulsions, head injury or other intracranial lesions, or a
             pre-existing increase in intracranial pressure

          -  Has any clinically significant abnormalities on physical examination, ECG, or
             laboratory values

          -  Treatment with any investigational drug within 30 days of administration of study drug
             in the Treatment Phase
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rita Jain, MD</last_name>
    <role>Study Director</role>
    <affiliation>Abbott</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5V 2T3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2007</study_first_submitted>
  <study_first_submitted_qc>January 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2007</study_first_posted>
  <last_update_submitted>October 24, 2007</last_update_submitted>
  <last_update_submitted_qc>October 24, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2007</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
    <mesh_term>Hydrocodone</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

